Ameriprise’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-34,900
Closed -$79.6K 4032
2024
Q2
$79.6K Sell
34,900
-600
-2% -$1.37K ﹤0.01% 3791
2024
Q1
$153K Hold
35,500
﹤0.01% 3724
2023
Q4
$108K Sell
35,500
-2,550
-7% -$7.78K ﹤0.01% 3806
2023
Q3
$54.8K Sell
38,050
-89,334
-70% -$129K ﹤0.01% 3833
2023
Q2
$317K Sell
127,384
-22,421
-15% -$55.8K ﹤0.01% 3592
2023
Q1
$401K Buy
149,805
+33,395
+29% +$89.5K ﹤0.01% 3503
2022
Q4
$632K Sell
116,410
-1,179
-1% -$6.4K ﹤0.01% 3314
2022
Q3
$1.47M Buy
117,589
+4,866
+4% +$60.7K ﹤0.01% 2928
2022
Q2
$557K Buy
112,723
+4,422
+4% +$21.9K ﹤0.01% 3358
2022
Q1
$823K Buy
108,301
+7,850
+8% +$59.7K ﹤0.01% 3289
2021
Q4
$1.03M Sell
100,451
-21,996
-18% -$224K ﹤0.01% 3239
2021
Q3
$1.64M Buy
122,447
+6,796
+6% +$91.2K ﹤0.01% 2947
2021
Q2
$2.54M Buy
115,651
+42,288
+58% +$928K ﹤0.01% 2828
2021
Q1
$1.77M Sell
73,363
-16,336
-18% -$393K ﹤0.01% 2902
2020
Q4
$1.61M Buy
89,699
+17,694
+25% +$318K ﹤0.01% 2883
2020
Q3
$832K Sell
72,005
-6,952
-9% -$80.3K ﹤0.01% 3046
2020
Q2
$1.92M Sell
78,957
-9,564
-11% -$232K ﹤0.01% 2625
2020
Q1
$976K Buy
88,521
+9,110
+11% +$100K ﹤0.01% 2835
2019
Q4
$2.1M Buy
79,411
+11,312
+17% +$299K ﹤0.01% 2712
2019
Q3
$1.55M Sell
68,099
-8,863
-12% -$202K ﹤0.01% 2816
2019
Q2
$2.36M Buy
76,962
+15,562
+25% +$477K ﹤0.01% 2647
2019
Q1
$1.02M Buy
61,400
+27,278
+80% +$453K ﹤0.01% 3029
2018
Q4
$654K Buy
+34,122
New +$654K ﹤0.01% 3095
2018
Q2
Sell
-30,769
Closed -$1.14M 3701
2018
Q1
$1.14M Buy
+30,769
New +$1.14M ﹤0.01% 2916